ArticleInternational forum of allergy & rhinology2026

Dosing Interval Extension of Dupilumab in CRSwNP: Five-Year Real World Outcomes.

Nicholas J Campion et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.